An update from Boston Scientific (BSX) is now available.
Boston Scientific Corporation has expanded its Board from ten to eleven members, appointing David C. Habiger as a new director until the next annual stockholders’ meeting. Mr. Habiger will also be a part of the Audit Committee and the Executive Compensation and Human Resources Committee. He is set to receive a pro-rata compensation package including a cash retainer and an equity award, with the exact number of shares to be determined at the time of grant. The company plans to execute an indemnification agreement with Habiger, similar to those with existing directors, and confirms that his appointment involves no other arrangements or material interests in any transactions.
See more insights into BSX stock on TipRanks’ Stock Analysis page.
